SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-099437
Filing Date
2016-02-17
Accepted
2016-02-17 17:42:42
Documents
1
Period of Report
2016-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7432
  Complete submission text file 0001209191-16-099437.txt   8834
Mailing Address C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
MCLAUGHLIN JOHN PETER (Reporting) CIK: 0001277967 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 161435263

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)